The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2020

Filed:

Nov. 20, 2016
Applicant:

Oregon Health & Science University, Portland, OR (US);

Inventors:

Jay Nelson, Lake Oswego, OR (US);

Scott Hansen, Portland, OR (US);

Meaghan H. Hancock, Aloha, OR (US);

Louis Picker, Portland, OR (US);

Klaus Frueh, Portland, OR (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C12N 15/86 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/00 (2013.01); A61K 39/12 (2013.01); C12N 15/86 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/552 (2013.01); A61K 2039/572 (2013.01); C12N 2710/16134 (2013.01); C12N 2710/16143 (2013.01); C12N 2710/16162 (2013.01); C12N 2740/15034 (2013.01);
Abstract

Disclosed herein are recombinant CMV vectors comprising heterologous antigens and microRNA recognition elements to silence expression of CMV genes in the presence of microRNA derived from myeloid cells, an active UL128 protein and an active UL130 protein. Also disclosed are recombinant CMV vectors comprising heterologous antigens and microRNA recognition elements to silence expression of CMV genes in the presence of microRNA derived from myeloid cells, an inactive UL128 protein and an inactive UL130 protein. Also disclosed are methods of generating an unconventional immune response using these vectors. Such an immune response is characterized by generation of a CD8+ T cell response that is predominantly restricted by MHC-II.


Find Patent Forward Citations

Loading…